# Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

> **NCT01279681** · PHASE3 · TERMINATED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 32 (actual)

## Conditions studied

- Cognitive/Functional Effects
- Colorectal Cancer
- Neurotoxicity

## Interventions

- **BIOLOGICAL:** bevacizumab
- **DRUG:** capecitabine
- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT01279681
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2014-11
- **Final completion:** 2014-11-01
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2017-12-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01279681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01279681, "Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT01279681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*